2021 ASCO Virtual Annual Meeting*

Download All
June 4-8, 2021; Online at https://conferences.asco.org/am
Expert faculty review and share their insights and perspectives on key findings in genitourinary cancers presented at the 2021 ASCO Annual Meeting.
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS

Genitourinary Cancers

Slidesets KEYNOTE-426: Preplanned Final Analysis of First-line Pembrolizumab + Axitinib vs Sunitinib for Advanced Clear-Cell Renal Cell Carcinoma
Slidesets KEYNOTE-052: 5-Yr Update of First-line Pembrolizumab in Cisplatin-Ineligible Advanced Urothelial Cancer
Slidesets KEYNOTE-045: 5-Yr Follow-up of Pembrolizumab in Recurrent Advanced Urothelial Cancer
Slidesets CheckMate 9ER: Efficacy of First-line Nivolumab + Cabozantinib vs Sunitinib in Advanced/Metastatic RCC by Baseline Patient Characteristics
Slidesets PEACE-1: Phase III Trial of Abiraterone With or Without Local Radiotherapy + SoC in de novo Metastatic Castration-Sensitive Prostate Cancer
Slidesets Updated Safety Analysis of Fracture Rate With Mandated Bone-Protecting Agents in Phase III EORTC GUCG 1333/PEACE-3 Trial of Enzalutamide ± Radium-223 in mCRPC
Slidesets VISION: 177Lu-PSMA-617 in Previously Treated Metastatic Castration-Resistant Prostate Cancer
Slidesets KEYNOTE-564: Adjuvant Pembrolizumab vs Placebo After Nephrectomy for Renal Cell Carcinoma

Expert faculty review and share their insights and perspectives on key findings in genitourinary cancers presented at the 2021 ASCO Annual Meeting.

Daniel P. Petrylak, MD Elizabeth R. Plimack, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: September 7, 2021 Expired: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Exelixis
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings